Does PATISIRAN Cause Product administration interrupted? 17 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Product administration interrupted have been filed in association with PATISIRAN (Onpattro). This represents 0.6% of all adverse event reports for PATISIRAN.
17
Reports of Product administration interrupted with PATISIRAN
0.6%
of all PATISIRAN reports
0
Deaths
4
Hospitalizations
How Dangerous Is Product administration interrupted From PATISIRAN?
Of the 17 reports, 4 (23.5%) required hospitalization.
Is Product administration interrupted Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PATISIRAN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does PATISIRAN Cause?
Death (250)
Product dose omission issue (175)
Fatigue (165)
Infusion related reaction (134)
Hospitalisation (127)
Asthenia (108)
Fall (107)
Intentional dose omission (107)
Cardiac failure (95)
Dyspnoea (87)
What Other Drugs Cause Product administration interrupted?
CALCIUM OXYBATE\MAGNESIUM OXYBATE\POTASSIUM OXYBATE\SODIUM OXYBATE (1,446)
SODIUM OXYBATE (1,272)
CANNABIDIOL (511)
ISOTRETINOIN (503)
APREMILAST (314)
TREPROSTINIL (295)
EPOPROSTENOL (205)
LENALIDOMIDE (146)
ETANERCEPT (142)
INTERFERON BETA-1A (115)
Which PATISIRAN Alternatives Have Lower Product administration interrupted Risk?
PATISIRAN vs PAXIL
PATISIRAN vs PAZOPANIB
PATISIRAN vs PEANUT
PATISIRAN vs PEG INTERFERON
PATISIRAN vs PEG-INTERFERON ALFA 2A